Regulation of T-type calcium channels: Signalling pathways and functional implications

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 6, 2009, Pages 947-952

  Huc, Sylvaine ^a,b   Monteil, Arnaud ^a,b   Bidaud, Isabelle ^a,b   Barbara, Guillaume ^a,b   Chemin, Jean ^a,b   Lory, Philippe ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Channelopathies; G protein coupled receptor; Low voltage activated; Phosphorylation; T type calcium channel

Indexed keywords

ANANDAMIDE; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; DIHYDROPYRIDINE DERIVATIVE; DIPHENYLBUTYLPIPERIDINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; OXIDIZING AGENT; PROTEIN KINASE; PROTEIN SUBUNIT; SUCCINIMIDE DERIVATIVE; ZINC;

AUTISM; BENIGN CHILDHOOD EPILEPSY; CALCIUM CHANNELOPATHY; CARDIOVASCULAR DISEASE; DISEASE MARKER; DRUG MECHANISM; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MODULATION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW;

ANIMALS; AUTISTIC DISORDER; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CHANNELOPATHIES; EPILEPSY; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; SIGNAL TRANSDUCTION;

EID: 67349197317     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.11.003     Document Type: Review

References (80)

1. Llinas R., and Jahnsen H. Electrophysiology of mammalian thalamic neurones in vitro. Nature 297 (1982) 406-408
2. Veselovskii N.S., and Fedulova S.A. [2 types of calcium channels in the somatic membrane of spinal ganglion neurons in the rat]. Dokl. Akad. Nauk SSSR 268 (1983) 747-750
3. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83 (2003) 117-161
4. Nilius B., Talavera K., and Verkhratsky A. T-type calcium channels: the never ending story. Cell Calcium 40 (2006) 81-88
5. Perez-Reyes E., and Lory P. Molecular biology of T-type calcium channels. CNS Neurol. Disord. Drug Targets 5 (2006) 605-609
6. Shin H.S., Cheong E.J., Choi S., Lee J., and Na H.S. T-type Ca2+ channels as therapeutic targets in the nervous system. Curr. Opin. Pharmacol. 8 (2008) 33-41
7. Todorovic S.M., and Jevtovic-Todorovic V. The role of T-type calcium channels in peripheral and central pain processing. CNS Neurol. Disord. Drug Targets 5 (2006) 639-653
8. Chemin J., Monteil A., Perez-Reyes E., Bourinet E., Nargeot J., and Lory P. Specific contribution of human T-type calcium channel isotypes (alpha1G, alpha1H and alpha1I) to neuronal excitability. J. Physiol. 540 (2002) 3-14
9. Monteil A., Chemin J., Bourinet E., Mennessier G., Lory P., and Nargeot J. Molecular and functional properties of the human alpha1G subunit that forms T-type calcium channels. J. Biol. Chem. 275 (2000) 6090-6100
10. Murbartian J., Arias J.M., Lee J.H., Gomora J.C., and Perez-Reyes E. Alternative splicing of the rat Cav3.3 T-type calcium channel gene produces variants with distinct functional properties. FEBS Lett. 528 (2002) 272-278
11. Zhong X., Liu J.R., Kyle J.W., Hanck D.A., and Agnew W.S. A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum. Mol. Genet. 15 (2006) 1497-1512
12. Chemin J., Monteil A., Bourinet E., Nargeot J., and Lory P. Alternatively spliced alpha1G (Cav3.1) intracellular loops promote specific T-type Ca2+ channel gating properties. Biophys. J. 80 (2001) 1238-1250
13. Emerick M.C., Stein R., Kunze R., McNulty M.M., Regan M.R., Hanck D.A., and Agnew W.S. Profiling the array of Cav3.1 variants from the human T-type calcium channel gene CACNA1G: alternative structures, developmental expression, and biophysical variations. Proteins 64 (2006) 320-342
14. Catterall W.A. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
15. Lacinova L. Voltage-dependent calcium channels. Gen. Physiol. Biophys. 24 Suppl 1 (2005) 1-78
16. Dubel S.J., Altier C., Chaumont S., Lory P., Bourinet E., and Nargeot J. Plasma membrane expression of T-type calcium channel alpha1 subunits is modulated by high voltage-activated auxiliary subunits. J. Biol. Chem. 279 (2004) 29263-29269
17. Lin Z., Witschas K., Garcia T., Chen R.S., Hansen J.P., Sellers Z.M., Kuzmenkina E., Herzig S., and Best P.M. A critical GxxxA motif in the gamma6 calcium channel subunit mediates its inhibitory effect on Cav3.1 calcium current. J. Physiol. 586 (2008) 5349-5366
18. Chen Y., Sharp A.H., Hata K., Yunker A.M., Polo-Parada L., Landmesser L.T., and McEnery M.W. Site-directed antibodies to low-voltage-activated calcium channel Cav3.3 alpha1I subunit also target neural cell adhesion molecule-180. Neuroscience 145 (2007) 981-996
19. Chemin J., Traboulsie A., and Lory P. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium 40 (2006) 121-134
20. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 20 (2001) 7033-7040
21. van der Stelt M., and Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 77 (2005) 111-122
22. Talavera K., Staes M., Janssens A., Droogmans G., and Nilius B. Mechanism of arachidonic acid modulation of the T-type Ca2+ channel alpha1G. J. Gen. Physiol. 124 (2004) 225-238
23. Chemin J., Nargeot J., and Lory P. Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels. J. Biol. Chem. 282 (2007) 2314-2323
24. Mathie A., Sutton G.L., Clarke C.E., and Veale E.L. Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol. Ther. 111 (2006) 567-583
25. Traboulsie A., Chemin J., Chevalier M., Quignard J.F., Nargeot J., and Lory P. Subunit-specific modulation of T-type calcium channels by zinc. J. Physiol. 578 (2007) 159-171
26. Nelson M.T., Joksovic P.M., Perez-Reyes E., and Todorovic S.M. The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J. Neurosci. 25 (2005) 8766-8775
27. Nelson M.T., Woo J., Kang H.W., Vitko I., Barrett P.Q., Perez-Reyes E., Lee J.H., Shin H.S., and Todorovic S.M. Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J. Neurosci. 27 (2007) 8250-8260
28. Kang H.W., Park J.Y., Jeong S.W., Kim J.A., Moon H.J., Perez-Reyes E., and Lee J.H. A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels. J. Biol. Chem. 281 (2006) 4823-4830
29. Nelson M.T., Joksovic P.M., Su P., Kang H.W., Van Deusen A., Baumgart J.P., David L.S., Snutch T.P., Barrett P.Q., Lee J.H., Zorumski C.F., Perez-Reyes E., and Todorovic S.M. Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J. Neurosci. 27 (2007) 12577-12583
30. Hildebrand M.E., David L.S., Hamid J., Mulatz K., Garcia E., Zamponi G.W., and Snutch T.P. Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors. J. Biol. Chem. 282 (2007) 21043-21055
31. Tao J., Hildebrand M.E., Liao P., Liang M.C., Tan G., Li S., Snutch T.P., and Soong T.W. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels. Mol. Pharmacol. 73 (2008) 1596-1609
32. Wolfe J.T., Wang H., Howard J., Garrison J.C., and Barrett P.Q. T-type calcium channel regulation by specific G-protein betagamma subunits. Nature 424 (2003) 209-213
33. DePuy S.D., Yao J., Hu C., McIntire W., Bidaud I., Lory P., Rastinejad F., Gonzalez C., Garrison J.C., and Barrett P.Q. The molecular basis for T-type Ca2+ channel inhibition by G protein beta2gamma2 subunits. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14590-14595
34. Welsby P.J., Wang H., Wolfe J.T., Colbran R.J., Johnson M.L., and Barrett P.Q. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J. Neurosci. 23 (2003) 10116-10121
35. Yao J., Davies L.A., Howard J.D., Adney S.K., Welsby P.J., Howell N., Carey R.M., Colbran R.J., and Barrett P.Q. Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II. J. Clin. Invest. 116 (2006) 2403-2412
36. Park J.Y., Kang H.W., Moon H.J., Huh S.U., Jeong S.W., Soldatov N.M., and Lee J.H. Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density. J. Physiol. 577 (2006) 513-523
37. Kim J.A., Park J.Y., Kang H.W., Huh S.U., Jeong S.W., and Lee J.H. Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A. J. Pharmacol. Exp. Ther. 318 (2006) 230-237
38. Chemin J., Mezghrani A., Bidaud I., Dupasquier S., Marger F., Barrere C., Nargeot J., and Lory P. Temperature-dependent modulation of Cav3 T-type calcium channels by protein kinases C and A in mammalian cells. J. Biol. Chem. 282 (2007) 32710-32718
39. Iftinca M., Hamid J., Chen L., Varela D., Tadayonnejad R., Altier C., Turner R.W., and Zamponi G.W. Regulation of T-type calcium channels by Rho-associated kinase. Nat. Neurosci. 10 (2007) 854-860
40. Zamponi G.W., Bourinet E., Nelson D., Nargeot J., and Snutch T.P. Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit. Nature 385 (1997) 442-446
41. Leresche N., Hering J., and Lambert R.C. Paradoxical potentiation of neuronal T-type Ca2+ current by ATP at resting membrane potential. J. Neurosci. 24 (2004) 5592-5602
42. Bessaih T., Leresche N., and Lambert R.C. T current potentiation increases the occurrence and temporal fidelity of synaptically evoked burst firing in sensory thalamic neurons. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 11376-11381
43. Tsakiridou E., Bertollini L., de Curtis M., Avanzini G., and Pape H.C. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J. Neurosci. 15 (1995) 3110-3117
44. Zhang Y., Mori M., Burgess D.L., and Noebels J.L. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J. Neurosci. 22 (2002) 6362-6371
45. Zhang Y., Vilaythong A.P., Yoshor D., and Noebels J.L. Elevated thalamic low-voltage-activated currents precede the onset of absence epilepsy in the SNAP25-deficient mouse mutant coloboma. J. Neurosci. 24 (2004) 5239-5248
46. Broicher T., Kanyshkova T., Landgraf P., Rankovic V., Meuth P., Meuth S.G., Pape H.C., and Budde T. Specific expression of low-voltage-activated calcium channel isoforms and splice variants in thalamic local circuit interneurons. Mol. Cell. Neurosci. 36 (2007) 132-145
47. Chen Y., Lu J., Pan H., Zhang Y., Wu H., Xu K., Liu X., Jiang Y., Bao X., Yao Z., Ding K., Lo W.H., Qiang B., Chan P., Shen Y., and Wu X. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann. Neurol. 54 (2003) 239-243
48. Heron S.E., Phillips H.A., Mulley J.C., Mazarib A., Neufeld M.Y., Berkovic S.F., and Scheffer I.E. Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann. Neurol. 55 (2004) 595-596
49. Heron S.E., Khosravani H., Varela D., Bladen C., Williams T.C., Newman M.R., Scheffer I.E., Berkovic S.F., Mulley J.C., and Zamponi G.W. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann. Neurol. 62 (2007) 560-568
50. Singh B., Monteil A., Bidaud I., Sugimoto Y., Suzuki T., Hamano S., Oguni H., Osawa M., Alonso M.E., Delgado-Escueta A.V., Inoue Y., Yasui-Furukori N., Kaneko S., Lory P., and Yamakawa K. Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online. Human Mutat. 28 (2007) 524-525
51. Vitko I., Chen Y., Arias J.M., Shen Y., Wu X.R., and Perez-Reyes E. Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel. J. Neurosci. 25 (2005) 4844-4855
52. Khosravani H., and Zamponi G.W. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol. Rev. 86 (2006) 941-966
53. Vitko I., Bidaud I., Arias J.M., Mezghrani A., Lory P., and Perez-Reyes E. The I-II loop controls plasma membrane expression and gating of Cav3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations. J. Neurosci. 27 (2007) 322-330
54. Baumgart J.P., Vitko I., Bidaud I., Kondratskyi A., Lory P., and Perez-Reyes E. I-II loop structural determinants in the gating and surface expression of low voltage-activated calcium channels. PLoS ONE 3 (2008) e2976
55. Arias II O., Vitko I., Fortuna M., Baumgart J.P., Sokolova S., Shumilin I.A., Van Deusen A., Soriano-Garcia M., Gomora J.C., and Perez-Reyes E. Characterization of the gating brake in the I-II loop of Cav3.2 T-type Ca2+ channels. J. Biol. Chem. 283 (2008) 8136-8144
56. Splawski I., Yoo D.S., Stotz S.C., Cherry A., Clapham D.E., and Keating M.T. CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281 (2006) 22085-22091
57. Lory P., Bidaud I., and Chemin J. T-type calcium channels in differentiation and proliferation. Cell Calcium 40 (2006) 135-146
58. Chemin J., Nargeot J., and Lory P. Neuronal T-type alpha1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J. Neurosci. 22 (2002) 6856-6862
59. Huang B., Qin D., Deng L., Boutjdir M., and N E.-S. Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc. Res. 46 (2000) 442-449
60. Ferron L., Capuano V., Deroubaix E., Coulombe A., and Renaud J.F. Functional and molecular characterization of a T-type Ca2+ channel during fetal and postnatal rat heart development. J. Mol. Cell. Cardiol. 34 (2002) 533-546
61. Ferron L., Capuano V., Ruchon Y., Deroubaix E., Coulombe A., and Renaud J.F. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ. Res. 93 (2003) 1241-1248
62. Izumi T., Kihara Y., Sarai N., Yoneda T., Iwanaga Y., Inagaki K., Onozawa Y., Takenaka H., Kita T., and Noma A. Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 108 (2003) 2530-2535
63. Su H., Sochivko D., Becker A., Chen J., Jiang Y., Yaari Y., and Beck H. Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J. Neurosci. 22 (2002) 3645-3655
64. Bourinet E., Alloui A., Monteil A., Barrere C., Couette B., Poirot O., Pages A., McRory J., Snutch T.P., Eschalier A., and Nargeot J. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J. 24 (2005) 315-324
65. Choi S., Na H.S., Kim J., Lee J., Lee S., Kim D., Park J., Chen C.C., Campbell K.P., and Shin H.S. Attenuated pain responses in mice lacking Ca3.2 T-type channels. Genes Brain Behav. (2006)
66. Jagodic M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksovic P.M., Rosenberg E.R., Bayliss D.A., Jevtovic-Todorovic V., and Todorovic S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J. Neurosci. 27 (2007) 3305-3316
67. Horiba M., Muto T., Ueda N., Opthof T., Miwa K., Hojo M., Lee J.K., Kamiya K., Kodama I., and Yasui K. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Life Sci. 82 (2008) 554-560
68. Jaleel N., Nakayama H., Chen X., Kubo H., MacDonnell S., Zhang H., Berretta R., Robbins J., Cribbs L., Molkentin J.D., and Houser S.R. Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes. Circ. Res. 103 (2008) 1109-1119
69. Mariot P., Vanoverberghe K., Lalevee N., Rossier M.F., and Prevarskaya N. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J. Biol. Chem. 277 (2002) 10824-10833
70. Gackiere F., Bidaux G., Delcourt P., Van Coppenolle F., Katsogiannou M., Dewailly E., Bavencoffe A., Van Chuoi-Mariot M.T., Mauroy B., Prevarskaya N., and Mariot P. Cav3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J. Biol. Chem. 283 (2008) 10162-10173
71. Toyota M., Ho C., Ohe-Toyota M., Baylin S.B., and Issa J.P. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors. Cancer Res. 59 (1999) 4535-4541
72. Belardetti F., and Zamponi G.W. Linking calcium-channel isoforms to potential therapies. Curr. Opin. Investig. Drugs 9 (2008) 707-715
73. McGivern J.G. Pharmacology and drug discovery for T-type calcium channels. CNS Neurol. Disord. Drug Targets 5 (2006) 587-603
74. Lory P., and Chemin J. Towards the discovery of novel T-type calcium channel blockers. Expert. Opin. Ther. Targets 11 (2007) 717-722
75. Furukawa T., Miura R., Honda M., Kamiya N., Mori Y., Takeshita S., Isshiki T., and Nukada T. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels. Br. J. Pharmacol. 143 (2004) 1050-1057
76. Doddareddy M.R., Choo H., Cho Y.S., Rhim H., Koh H.Y., Lee J.H., Jeong S.W., and Pae A.N. 3D pharmacophore based virtual screening of T-type calcium channel blockers. Bioorg. Med. Chem. 15 (2007) 1091-1105
77. Yang Z.Q., Barrow J.C., Shipe W.D., Schlegel K.A., Shu Y., Yang F.V., Lindsley C.W., Rittle K.E., Bock M.G., Hartman G.D., Uebele V.N., Nuss C.E., Fox S.V., Kraus R.L., Doran S.M., Connolly T.M., Tang C., Ballard J.E., Kuo Y., Adarayan E.D., Prueksaritanont T., Zrada M.M., Marino M.J., Graufelds V.K., DiLella A.G., Reynolds I.J., Vargas H.M., Bunting P.B., Woltmann R.F., Magee M.M., Koblan K.S., and Renger J.J. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. J. Med. Chem. 51 (2008) 6471-6477
78. Kim D., Song I., Keum S., Lee T., Jeong M.J., Kim S.S., McEnery M.W., and Shin H.S. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha1G T-type Ca2+ channels. Neuron 31 (2001) 35-45
79. Mangoni M.E., Traboulsie A., Leoni A.L., Couette B., Marger L., Le Quang K., Kupfer E., Cohen-Solal A., Vilar J., Shin H.S., Escande D., Charpentier F., Nargeot J., and Lory P. Bradycardia and slowing of the atrioventricular conduction in mice lacking Cav3.1/alpha1G T-type calcium channels. Circ. Res. 98 (2006) 1422-1430
80. Chen C.C., Lamping K.G., Nuno D.W., Barresi R., Prouty S.J., Lavoie J.L., Cribbs L.L., England S.K., Sigmund C.D., Weiss R.M., Williamson R.A., Hill J.A., and Campbell K.P. Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science 302 (2003) 1416-1418